Media - Page 7

Revolutionizing Biotech: MSB’s Game-Changer on ASX

Revolutionizing Biotech: MSB’s Game-Changer on ASX

Mesoblast Limited, trading as MSB on the ASX, is pioneering cellular medicines with a focus on regenerative treatments for chronic diseases. Innovative research in mesenchymal lineage cells is paving the way for personalized medicine, targeting complex diseases like inflammatory and cardiovascular disorders.
12 February 2025
1 5 6 7 8 9 93